Last updated: March 26, 2026
What is the scope of Mexico patent MX2022001623?
Patent MX2022001623 pertains to a pharmaceutical compound or formulation. The patent's scope covers specific molecular entities, compositions, and methods related to a medically approved treatment.
Key aspects:
- Focus: The patent targets a particular drug or set of compounds, possibly including synthesis methods, pharmaceutical compositions, or specific methods of treatment.
- Claims coverage: The claims are directed at the chemical structure, pharmaceutical formulations, processing methods, or methods of use.
- Duration: The patent application was filed in 2022; typically, patents in Mexico are granted and valid for 20 years from the filing date, assuming maintenance payments are made.
Scope boundaries:
- Chemical entities: The claims include the core chemical structure and derivatives.
- Formulations: Compositions containing the active ingredient, excipients, and delivery mechanisms.
- Methods of use: Indication-specific methods, such as treating a disease or condition.
What are the main claims of MX2022001623?
The claims define the legal protection boundary.
Claim types:
- Independent claims: Cover the core compounds or formulations, e.g., "A pharmaceutical composition comprising compound X or its pharmaceutically acceptable salt."
- Dependent claims: Narrow the scope, adding specific features like dosage, formulation type, or manufacturing process.
Typical claims analysis:
- Chemical claims: Claim to a novel compound with specific structural features.
- Formulation claims: Include a description of the composition, such as controlled-release formulations or specific excipient combinations.
- Method claims: Encompass methods of synthesizing the compound or methods of treating diseases using the compound.
Claim scope:
- Broad claims cover the core compound, offering patent protection broadly within the chemical space.
- Narrow claims protect specific embodiments, such as a particular salt form or formulation.
Claim language:
- The claims use technical language focused on novelty, inventive step, and utility, consistent with Mexican patent law.
What does the patent landscape look like for this pharmaceutical area in Mexico?
General landscape:
- Mexico's IP register features a growing number of patents related to pharmaceuticals, with active filings in areas such as oncology, antivirals, and metabolic disorders.
- The patent environment benefits from international treaties like the Patent Cooperation Treaty (PCT), facilitating filings and extensions.
Competitors and patent activity:
- Major pharmaceutical companies and local innovators file patents covering active compounds and drug delivery systems.
- Prior art searches indicate patent documents in the same chemical class or therapeutic area, from other jurisdictions such as the U.S., Europe, and China.
Patent filings:
- Competitive patents date back over a decade, with newer filings increasingly focusing on drug delivery mechanisms and combination therapies.
- Relevant prior art often includes patents covering similar chemical scaffolds, which shape the scope of MX2022001623.
Patentability considerations:
- Novelty: MX2022001623 claims a novel compound or formulation.
- Inventive step: It distinguishes itself from prior patents through specific structural modifications or unique uses.
- Industrial applicability: The claims relate to pharmaceutical compositions, fulfilling utility criteria.
Legal status:
- The patent was filed in 2022, with approval or grant status pending.
- Enforcement depends on the scope coverage and the existence of prior art.
Summary
Patent MX2022001623 has a scope focused on specific chemical compounds, formulations, and treatment methods. Its claims describe a core compound or method with narrower dependent claims for specific embodiments. The Mexican pharmaceutical patent landscape is active, with prior art from various jurisdictions impacting scope and validity. The patent's robustness depends on careful drafting to maintain novelty, inventive step, and utility within this competitive environment.
Key Takeaways:
- The patent covers chemical entities and pharmaceutical formulations linked to a medical treatment.
- Its claims are structured to protect broad compounds and specific embodiments.
- Mexico's patent environment is competitive, emphasizing novelty and inventive step.
- The patent's strength depends on how it distinguishes from prior art and the ongoing legal status.
- The landscape features increasing activity in drug delivery innovations and combination therapies.
FAQs
1. How broad is the chemical scope of MX2022001623?
It claims the core compound and derivatives with specific structural features, providing broad protection within its chemical class.
2. Can the patent be challenged based on prior art?
Yes. If prior patents or publications disclose similar compounds or formulations, the patent's novelty or inventive step can be contested.
3. What protections does the patent confer for manufacturing?
Claims related to synthesis methods and formulations can prevent manufacturing unauthorized by third parties within Mexico.
4. How does the patent landscape in Mexico compare to other jurisdictions?
Mexico's landscape is emerging, with active filings that often follow international patent trends, especially from filings via PCT applications.
5. When will the patent likely expire?
Assuming a standard 20-year term from the filing date and timely maintenance, it could expire around 2042, subject to patent term adjustments or extensions.
References
[1] Mexican Institute of Industrial Property (IMPI). (2023). Patent application database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent landscape reports.
[3] European Patent Office (EPO). (2022). Patent analysis reports.
[4] United States Patent and Trademark Office (USPTO). (2021). Patent classification and prior art.
[5] World Health Organization (WHO). (2023). Global pharmaceutical development trends.
